Dive into the archives.
- TDI featured in DiarioMedico.com
TDI featured in DiarioMedico.com Today we have been featured at the Spanish main Medical daily journal Diario Médico. You can read more 20110715_DM_page13 (Spanish).
- More good news for tropical disease research!
New active compounds against Malaria from the GSK libraries GlaxoSmithKline (GSK) screened nearly 2 million compounds from their chemical library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 mM concentration. More than 8,000 also showed potent activity against the multidrug resistant strain Dd2. [...]
- Open Science discussed in Chemistry in Australia
Open Science discussed in Chemistry in Australia Our friend Matthew Todd talks about Open Science in general in this Q & A in the Chemistry in Australia Journal. You can read more here.
- More on our TDI kernel. Now in PLoS NTD!
PLoS Neglected Tropical Diseases published with full details our kernel. The detailed description on how our The Tropical Disease Initiative kernel was produced have been published in the last issue of the PLoS Neglected Tropical Diseases journal. You can read about it in the PLoS NTD site at this link. For fair use, you can download the PDF here. [...]
- Our TDI kernel has been published!
Nature Biotech published our kernel. The Tropical Disease Initiative kernel has been published in the last issue of the Nature Biotechnology journal as a correspondence to the Editor. You can read about it in the NatBioTech site at this link. The whole kernel will be published soon in the PLoS Neglected Tropical Diseases journal. We’ll [...]
- Open Source Drug Discovery. A feasible business model?
Open Source Drug Discovery. A feasible business model? Jagadeesh Napa (Assistant Editor of Pharma Focus Asia) has a nice assay on Open Source Drug Discovery and is feasibility as a business model. We are glad that Jagadeesh has named TDI as one of the “major open source initiatives”.
- 2008 Target Competition for Neglected Diseases (UC Berkeley)
2008 Target Competition for Neglected Diseases (UC Berkeley) As part of their upcoming symposium, Infection & Host Response (Dec. 12, 2008 at UC Berkeley, http://cend.berkeley.edu), the UC Berkeley Center for Emerging and Neglected Diseases is sponsoring a Target Competition in which the winner will receive a screen of up to 100,000 molecules in the QB3 Small Molecule Discovery Center (SMDC).
- Maurer on Open Source Drug Discovery
Open Source Drug Discovery: Finding A Niche In retrospect, it was probably inevitable that admirers of open source software production would look for a second act. Before the 1990s, most commentators had imagined that the landscape of innovation consisted almost entirely of patents and copyright. This was never really true – careful policy makers have always considered [...]
- TDI/TSL manuscript
Jul. 10th, 2006 Matt Todd of the TDI/TSL has put together a nice piece on Open source biology. Academic and industrial scientific research operate on powerful and complementary models, consisting of some mix of competitive funding, peer review, and limited inter-laboratory collaboration. Enormous successes have arisen from both models. Yet there are clear failures to deliver [...]
- PLoS Medicine
Dec. 1st, 2004 PLoS Medicine accepts and publishes the first paper on TDI. Read it here. Open-source drug discovery is feasible—that is, no known scientific or economic barrier bars the way. Stephen Maurer, Arti Rai and Andrej Sali
